Published in Health Business Week, September 15th, 2006
Results for the 3 months ended June 30, 2006, including discontinued operations, was a net loss of $152,900 or $0.02 per common share, on 7.5 million shares outstanding. This compares to a net loss of $769,446, or $0.11 per common (diluted) share, on 7.2 million shares outstanding in the second quarter of 2005. Sales totaled $2.4 million for the quarter compared to sales of $3.5 million for the quarter ended June 30, 2005.
Sales for the first 6 months of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week